Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
FRC
First Republic Bank
FRC
|
+$734M |
| 2 |
Boeing
BA
|
+$493M |
| 3 |
Pfizer
PFE
|
+$478M |
| 4 |
UnitedHealth
UNH
|
+$440M |
| 5 |
Honeywell
HON
|
+$364M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.05B |
| 2 |
Advanced Micro Devices
AMD
|
+$447M |
| 3 |
TSMC
TSM
|
+$441M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$372M |
| 5 |
ExxonMobil
XOM
|
+$321M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.34% |
| 2 | Technology | 16.84% |
| 3 | Consumer Discretionary | 12.66% |
| 4 | Industrials | 10.11% |
| 5 | Consumer Staples | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3626
Innovative Eyewear
LUCY
$6M
| $58K | ﹤0.01% |
+1,795
| New | +$62.3K |
|
|
SYBX
3627
DELISTED
Synlogic
SYBX
| $58K | ﹤0.01% |
6,127
-300
| -5% | -$3.56K |
|
3628
TMC The Metals Company
TMC
$1.54B
| $58K | ﹤0.01% |
70,100
-57,800
| -45% | -$53.7K |
|
3629
VerifyMe
VRME
$9.38M
| $58K | ﹤0.01% |
30,308
-5,192
| -15% | -$8.87K |
|
3630
Exicure
XCUR
$10.2M
| $58K | ﹤0.01% |
13,220
-1,100
| -8% | -$6.75K |
|
|
CUEN
3631
DELISTED
Cuentas Inc. Common Stock
CUEN
| $58K | ﹤0.01% |
10,585
+6,570
| +164% | +$60.3K |
|
|
ADAG
3632
Adagene
ADAG
$248M
| $57K | ﹤0.01% |
39,641
-34,959
| -47% | -$59.4K |
|
3633
Twin Vee PowerCats
VEEE
$6.68M
| $57K | ﹤0.01% |
92
+53
| +136% | +$38.8K |
|
|
TFFP
3634
DELISTED
TFF Pharmaceuticals, Inc. Common Stock
TFFP
| $57K | ﹤0.01% |
3,304
+418
| +14% | +$9.06K |
|
|
APTX
3635
DELISTED
Aptinyx Inc. Common Stock
APTX
| $56K | ﹤0.01% |
452,226
-166,000
| -27% | -$60.5K |
|
3636
Austin Gold Corp
AUST
$13.7M
| $55K | ﹤0.01% |
48,089
-33,033
| -41% | -$33.6K |
|
|
BWAY
3637
Brainsway
BWAY
$611M
| $55K | ﹤0.01% |
+62,830
| New | +$63.3K |
|
3638
Flotek Industries
FTK
$852M
| $55K | ﹤0.01% |
+13,258
| New | +$87.2K |
|
3639
Oriental Culture Holding
OCG
$3.12M
| $55K | ﹤0.01% |
40
-14
| -26% | -$28.2K |
|
3640
Oragenics
OGEN
$2.26M
| $55K | ﹤0.01% |
560
+400
| +250% | +$66.7K |
|
|
ORGS
3641
DELISTED
Orgenesis Inc. Common Stock
ORGS
| $55K | ﹤0.01% |
4,620
-130
| -3% | -$2.44K |
|
|
NURO
3642
DELISTED
NeuroMetrix, Inc. Common Stock
NURO
| $55K | ﹤0.01% |
4,685
+78
| +2% | +$1.06K |
|
3643
Elicio Therapeutics
ELTX
$73.5M
| $54K | ﹤0.01% |
9,302
-2,868
| -24% | -$19.1K |
|
3644
Upexi
UPXI
$55.5M
| $54K | ﹤0.01% |
665
-380
| -36% | -$29.4K |
|
|
HMPT
3645
DELISTED
Home Point Capital, Inc Common Stock
HMPT
| $54K | ﹤0.01% |
27,900
+1,400
| +5% | +$2.57K |
|
|
BSQR
3646
DELISTED
BSQUARE Corporation
BSQR
| $54K | ﹤0.01% |
49,000
-6,120
| -11% | -$7.36K |
|
3647
Aveanna Healthcare
AVAH
$2.04B
| $53K | ﹤0.01% |
50,900
+25,400
| +100% | +$30.2K |
|
3648
Heartbeam
BEAT
$27.8M
| $53K | ﹤0.01% |
+23,568
| New | +$82.7K |
|
3649
CN Energy Group
CNEY
$4.65M
| $53K | ﹤0.01% |
334
+302
| +944% | +$122K |
|
|
KORE
3650
DELISTED
KORE Group Holdings
KORE
| $53K | ﹤0.01% |
8,720
-2,400
| -22% | -$20.3K |
|
Similar funds
Renaissance Technologies's Q1 2023 Portfolio in Review
As of Q1 2023, Renaissance Technologies held 4,600 positions worth $75.4B, up 3.1% from $73.1B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Renaissance Technologies's Q1 2023 filing shows 524 new, 1,665 increased, 1,689 reduced and 668 closed positions. Its largest new stake was Honeywell: 1,937,917 shares worth $349M. The largest sale was Apple, an estimated $1.05B.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Technology and Consumer Discretionary.
- Renaissance Technologies's largest Q1 2023 buy was Honeywell: 1,937,917 shares worth $349M.
- Renaissance Technologies added most to First Republic Bank in Q1 2023, an estimated $734M increase.
- Renaissance Technologies's biggest Q1 2023 reduction was Apple, cutting an estimated $1.05B.
- Renaissance Technologies fully exited Advanced Micro Devices in Q1 2023, selling an estimated $447M.
- Renaissance Technologies's ten largest holdings make up 11% of its $75.4B portfolio in Q1 2023.
- Renaissance Technologies opened 524 new positions and closed 668 in Q1 2023.
- Renaissance Technologies's portfolio value rose 3.1% quarter-over-quarter to $75.4B.
Based on Renaissance Technologies's 13F filing for Q1 2023, filed 12 May 2023.